General Announcement::UPDATES TO SHAREHOLDERS ON PROCEEDINGS COMMENCED BY WEIXIN HOSPITAL INVESTMENT MANAGEMENT (SHANGHAI)

Issuer & Securities

Issuer/ Manager
OUE LIPPO HEALTHCARE LIMITED
Securities
OUE LIPPO HEALTHCARE LTD - SG2F86994413 - 5WA
OUELIPPO HC S$50M6%N180206 - SG6VF1000009 - 24AB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
20-Dec-2017 22:37:56
Status
New
Announcement Sub Title
UPDATES TO SHAREHOLDERS ON PROCEEDINGS COMMENCED BY WEIXIN HOSPITAL INVESTMENT MANAGEMENT (SHANGHAI)
Announcement Reference
SG171220OTHR2XSS
Submitted By (Co./ Ind. Name)
Dr Wong Weng Hong
Designation
Chief Executive Officer and Executive Director
Description (Please provide a detailed description of the event in the box below)
Please see attached.

This announcement has been prepared by OUE Lippo Healthcare Limited (formerly known as International Healthway Corporation Limited) (the "Company") and its contents have been reviewed by PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"), for compliance with the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist. The Sponsor has not verified the contents of this announcement. This announcement has not been examined or approved by the SGX-ST. The Sponsor and the SGX-ST assume no responsibility for the contents of this announcement, including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms Gillian Goh, Director, Head of Continuing Sponsorship (Mailing Address: 16 Collyer Quay, #10-00 Income at Raffles, Singapore 049318 and E-mail: sponsorship@ppcf.com.sg).

Attachments